Swedbank Ab Guardant Health, Inc. Transaction History

Swedbank Ab

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 09, 2024	SELL	$43.66 - $61.0 $10.9 Million - $15.3 Million	-250,000 Closed	0 $0
Q2 2022 Dec 09, 2024	BUY	$28.82 - $77.35 $2.16 Million - $5.8 Million	75,000 Added 42.86%	250,000 $10.1 Million
Q1 2022 Dec 09, 2024	BUY	$48.25 - $100.49 $8.44 Million - $17.6 Million	175,000 New	175,000 $11.6 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.